Literature DB >> 2823268

Antigen/major histocompatibility complex-specific activation of murine T cells transfected with functionally rearranged T-cell receptor genes.

C L Kuo1, L Hood.   

Abstract

The genes encoding the alpha and beta chains of the T-cell antigen receptor isolated from a cytochrome c-specific, major histocompatibility complex (MHC)-restricted murine T-cell hybridoma were introduced into a mouse T-cell line of helper lineage by electroporation. In order to examine the contributions of those gene products to antigen and/or MHC specificity, the resultant transfectants were tested for functional antigen and/or MHC recognition. Only those transfectants that express both the introduced genes (alpha and beta) contributed by the normal T cell can respond specifically to the appropriate antigen/MHC pair. None of the transfectants that express only one of the introduced genes (alpha or beta) of the normal T cell, or paired hybrid genes (i.e., one gene from the normal T cell and the other from the fusion partner), can respond to the same combination of antigen and MHC product recognized by the donor T cell. However, one clone expressing the transfected genes that encode the alpha and beta chains of the fusion partner shows reactivity to the antigen-presenting cells even in the absence of the antigens. These data suggest that the alpha beta heterodimer of the T-cell receptor is required to define the fine specificity of a T cell.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2823268      PMCID: PMC299350          DOI: 10.1073/pnas.84.21.7614

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  30 in total

1.  The T cell receptor: the alpha and beta chains define idiotype, and antigen and MHC specificity.

Authors:  J Yagüe; J White; C Coleclough; J Kappler; E Palmer; P Marrack
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

2.  Rearranged beta T cell receptor genes in a helper T cell clone specific for lysozyme: no correlation between V beta and MHC restriction.

Authors:  J Goverman; K Minard; N Shastri; T Hunkapiller; D Hansburg; E Sercarz; L Hood
Journal:  Cell       Date:  1985-04       Impact factor: 41.582

3.  Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter.

Authors:  P J Southern; P Berg
Journal:  J Mol Appl Genet       Date:  1982

4.  A third type of murine T-cell receptor gene.

Authors:  Y Chien; D M Becker; T Lindsten; M Okamura; D I Cohen; M M Davis
Journal:  Nature       Date:  1984 Nov 1-7       Impact factor: 49.962

5.  Diversity and structure of genes of the alpha family of mouse T-cell antigen receptor.

Authors:  B Arden; J L Klotz; G Siu; L E Hood
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

Review 6.  Biochemistry and distribution of the T cell receptor.

Authors:  C Hannum; J H Freed; G Tarr; J Kappler; P Marrack
Journal:  Immunol Rev       Date:  1984-10       Impact factor: 12.988

7.  Reconstitution of an active surface T3/T-cell antigen receptor by DNA transfer.

Authors:  P S Ohashi; T W Mak; P Van den Elsen; Y Yanagi; Y Yoshikai; A F Calman; C Terhorst; J D Stobo; A Weiss
Journal:  Nature       Date:  1985 Aug 15-21       Impact factor: 49.962

8.  Enhancer-dependent expression of human kappa immunoglobulin genes introduced into mouse pre-B lymphocytes by electroporation.

Authors:  H Potter; L Weir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  The murine T-cell receptor uses a limited repertoire of expressed V beta gene segments.

Authors:  R K Barth; B S Kim; N C Lan; T Hunkapiller; N Sobieck; A Winoto; H Gershenfeld; C Okada; D Hansburg; I L Weissman
Journal:  Nature       Date:  1985 Aug 8-14       Impact factor: 49.962

10.  The T lymphocyte response to cytochrome c. IV. Distinguishable sites on a peptide antigen which affect antigenic strength and memory.

Authors:  D Hansburg; T Fairwell; R H Schwartz; E Appella
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

View more
  6 in total

1.  Immunoregulatory activity of the T-cell receptor alpha chain demonstrated by retroviral gene transfer.

Authors:  D R Green; R Bissonnette; H G Zheng; T Onda; F Echeverri; R J Mogil; J K Steele; M Voralia; A Fotedar
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

2.  Highly conserved T-cell receptor junctional regions. Evidence for selection at the protein and the DNA level.

Authors:  S B Sorger; S M Hedrick
Journal:  Immunogenetics       Date:  1990       Impact factor: 2.846

3.  A conserved sequence block in murine and human T cell receptor (TCR) Jalpha region is a composite element that enhances TCR alpha enhancer activity and binds multiple nuclear factors.

Authors:  C L Kuo; M L Chen; K Wang; C K Chou; B Vernooij; D Seto; B F Koop; L Hood
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

4.  CD28 Deficiency Ameliorates Blast Exposure-Induced Lung Inflammation, Oxidative Stress, Apoptosis, and T Cell Accumulation in the Lungs via the PI3K/Akt/FoxO1 Signaling Pathway.

Authors:  Yunen Liu; Changci Tong; Ying Xu; Peifang Cong; Ying Liu; Lin Shi; Xiuyun Shi; Yan Zhao; Guangyuan Bi; Hongxu Jin; Mingxiao Hou
Journal:  Oxid Med Cell Longev       Date:  2019-09-02       Impact factor: 6.543

5.  T cell receptor gene usage in the response to lambda repressor cI protein. An apparent bias in the usage of a V alpha gene element.

Authors:  M Z Lai; S Y Huang; T J Briner; J G Guillet; J A Smith; M L Gefter
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

6.  CD28 Deficiency Ameliorates Thoracic Blast Exposure-Induced Oxidative Stress and Apoptosis in the Brain through the PI3K/Nrf2/Keap1 Signaling Pathway.

Authors:  Peifang Cong; Changci Tong; Ying Liu; Lin Shi; Xiuyun Shi; Yan Zhao; Keshen Xiao; Hongxu Jin; Yunen Liu; Mingxiao Hou
Journal:  Oxid Med Cell Longev       Date:  2019-12-04       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.